MCC
AGN

Mid Continent Capital’s Allergan Inc AGN Stock Holding History

Mid Continent Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-50,555
Closed -$10.7M – 325
2014
Q4 		$10.7M Buy
50,555
+85
+0.2% +$16.9K 0.61% 48
2014
Q3 		$8.99M Sell
50,470
-10,788
-18% -$1.79M 0.52% 51
2014
Q2 		$10.4M Sell
61,258
-132,862
-68% -$20.7M 0.6% 45
2014
Q1 		$24.1M Buy
194,120
+1,340
+0.7% +$163K 1.45% 20
2013
Q4 		$21.4M Sell
192,780
-34,585
-15% -$3.3M 1.32% 19
2013
Q3 		$20.6M Buy
227,365
+23,862
+12% +$2.14M 1.45% 18
2013
Q2 		$17.1M Buy
+203,503
New +$21.1M 1.25% 26

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Mid Continent Capital's AGN Position: Q1 2015 in Review

Mid Continent Capital sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 50,555 shares — an estimated $10.7M sold.

Mid Continent Capital first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $24.1M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Mid Continent Capital reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Mid Continent Capital sold 50,555 Allergan Inc shares in Q1 2015, an estimated $10.7M.
  • Mid Continent Capital first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Mid Continent Capital's Allergan Inc position peaked at $24.1M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Mid Continent Capital's 13F filing for Q1 2015, filed 21 Apr 2015.